Candice Sexil
Psychiatric/Mental Health · Riverview, FLNPI 1356944276
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 746 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 746 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Neurocrine Biosciences, Inc.$2K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$928
- plus $6K from 20 others
What the payments were for
- Food & beverage$15,056100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 163 | $2,827 |
| Neurocrine Biosciences, Inc. | 124 | $1,905 |
| Johnson & Johnson | 43 | $1,310 |
| Alkermes, Inc. | 62 | $1,219 |
| Otsuka America Pharmaceutical, Inc. | 76 | $1,151 |
| Teva Pharmaceuticals USA, Inc. | 49 | $928 |
| Corium, LLC | 42 | $895 |
| Vanda Pharmaceuticals Inc. | 22 | $846 |
| Axsome Therapeutics, Inc. | 12 | $637 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $533 |
| Lundbeck LLC | 21 | $476 |
| Noven Therapeutics, LLC | 17 | $382 |
| E.r. Squibb & Sons, L.L.C. | 10 | $344 |
| Bausch Health US, LLC | 17 | $338 |
| Idorsia Pharmaceuticals US Inc | 9 | $266 |
| Avanir Pharmaceuticals, Inc. | 6 | $147 |
| Collegium Pharmaceutical, Inc. | 8 | $145 |
| Almatica Pharma LLC | 7 | $131 |
| Merck | 8 | $131 |
| Neos Therapeutics, LP | 7 | $111 |
| Ironshore Pharmaceuticals Inc. | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Tris Pharma Inc | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| Eisai Inc. | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,080 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 17 | $133,831 |
| VraylarCariprazine Hcl | 15 | $20,909 |
| Aripiprazole | 38 | $1,465 |
| Armodafinil | 16 | $1,437 |
| Duloxetine Hcl | 84 | $1,061 |
| Quetiapine Fumarate | 91 | $912 |
| Clonazepam | 101 | $884 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $799 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 20 | $774 |
| Alprazolam | 172 | $709 |
| Vilazodone Hcl | 13 | $634 |
| Bupropion XlBupropion Hcl | 44 | $570 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $313 |
| Lurasidone Hcl | 12 | $311 |
| Buspirone Hcl | 24 | $296 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,905 | $133,83117 claims |
| AbbVieVraylar | $2,827 | $20,90915 claims |
| Almatica Pharma LLCSertraline Hcl | $131 | $23441 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Riverview
- Luisa VegaRiverview$30K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.